Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Drug Resistance

  Free Subscription

Articles published in Antivir Ther

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    December 2023
  1. MARGOT N, Pennetzdorfer N, Naik V, Rhee M, et al
    Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA.
    Antivir Ther. 2023;28:13596535231220754.
    PubMed     Abstract available

    August 2022
  2. BELLO G, Kagoli M, Chipeta S, Auld A, et al
    Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi.
    Antivir Ther. 2022;27:13596535221121225.
    PubMed     Abstract available

    June 2022
  3. MUSENGIMANA G, Tuyishime E, Kiromera A, Malamba SS, et al
    Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
    Antivir Ther. 2022;27:13596535221102690.
    PubMed     Abstract available

    April 2022
  4. ROEDIGER R, Smyth EK, Dieterich D
    Adefovir for lamivudine-resistant hepatitis B.
    Antivir Ther. 2022;27:13596535211067605.
    PubMed     Abstract available

    May 2021
  5. SCHEIBE K, Urbanska A, Jakubowski P, Hlebowicz M, et al
    Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)-infected patients.
    Antivir Ther. 2021;26.
    PubMed     Abstract available

    October 2020
  6. JIA J, Shang J, Tang H, Jiang J, et al
    Long-term outcomes in Chinese patients with chronic hepatitis B receiving nucleoside/nucleotide analogue therapy in real-world clinical practice: 5-year results from the EVOLVE study.
    Antivir Ther. 2020 Oct 22. doi: 10.3851/IMP3372.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.